Pfizer Global Medical Grants (GMG): CDK 4/6 Inhibitors & Understanding Real World Evidence

This Request for Proposal (RFP) intends to:

  • support educational initiatives and tools to help health care professionals analyze and interpret real world evidence (RWE) in terms of the study validity, study design, and data source so that they can accurately interpret the findings in an oncology setting;
  • help health care professionals understand the evidence that currently exists in terms of the real-world clinical experience in the field of CDK 4/6 inhibitors in metastatic breast cancer;
  • teach health care professionals how they might incorporate and appropriately apply RWE into daily practice and decision making in a metastatic breast cancer setting.

Funding & Duration

Up to USD $250,000 (approx. AUD $366,000) for a period of up to 2 years.


Submission Requirements & Due Date

Further Information

Need Help?

This entry was posted in Funding by Award Type, Funding by Faculty, Grants (Project Funds), Health & Medical Sciences, International Funding. Bookmark the permalink.

Comments are closed.